Article

But My Patients Are Sicker!

Author(s):

In "Getting Past Denial — The High Cost of Health Care in the United States," the authors observe, again, Jack Wennberg's (Dartmouth) dictum written about extensively at the end of the last century and earlier—the cost differences between regions and practices may be unwarranted.

In "Getting Past Denial — The High Cost of Health Care in the United States," the authors observe, again, Jack Wennberg's (Dartmouth) dictum written about extensively at the end of the last century and earlier—the cost differences between regions and practices may be unwarranted.

Southerland, Fisher and Skinner, also of Dartmouth say that "substantial savings can be achieved without rationing beneficial care" as they observe that "patient outcomes are no worse in low-utilization regions, nor do elderly people who live there feel as if they’re being denied necessary care.5" Indeed, "The key to attaining these cost-saving goals comes from getting the same (or better) outcome at a lower cost." They provide two classic, win-win, managed care industry examples of cost-efficient and otherwise better outcomes:

  • The outpatient, rather than the revolving door of inpatient management of congestive heart failure (CHF).
  • The conservative management of lower back pain (without neuropathy), especially by not jumping the gun on MRIs that can have a 50% or more false positive rate.

But they complain—"These are all good ideas, but they suffer from a common shortcoming: they require more time on the part of the primary care physician, the nurse, or the specialist — time that is not currently reimbursed [emphasis, jgk]. Eliminating unnecessary care therefore requires reorganizing the delivery system to ensure that providers aren’t penalized for providing what is often the better alternative for their patients."

And that's the rub.... There is "so much discretionary care.... provided in the United States that we could easily afford to expand coverage without increasing taxes — or rationing care — as long as we couple coverage expansion with a commitment to rapidly test and broadly implement successful reforms in payment and delivery systems. After all, many U.S. regions have already shown that they can slow the growth of spending while providing high-quality care."

References:

Please see the posting for the references, above. The article (10.1056/NEJMp0907172) was published on September 9, 2009, at NEJM.org. and is from the Dartmouth Institute for Health Policy and Clinical Practice (J.M.S., J.S.S.) and Dartmouth Medical School (E.S.F.) — both in Lebanon, NH; and Dartmouth College (J.S.S.), Hanover, NH.

Jason M. Sutherland, PhD, Elliott S. Fisher, MD, MPH, and Jonathan S. Skinner, PhD. "Getting Past Denial — The High Cost of Health Care in the United States" Posted by N. Eng J Med. September 9th, 2009 [PDF]

See also, my posts on this important subject brought to light anew:

"One Cannot Measure What One Does Not Manage": Managed Care 101 in 2010 (Part XIII)

Inaugurating Health Care Reform: Cause and Effect Techniques in Managed Care in 2010 (Part I-e)

Related Videos
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
Erin Michos, MD: HFpEF in Women and Sex-Specific Therapeutic Approaches | Image Credit: Johns Hopkins
AMG0001 Advances Healing in CLTI with David G. Armstrong, DPM, PhD, and Michael S. Conte, MD | Image Credit: Canva
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Muthiah Vaduganathan, MD, MPH | Credit: Brigham and Women's Hospital
Orly Vardeny, PharmD | Credit: JACC Journals
Barry A. Borlaug, MD: Impact of Tirzepatide on Cardiorenal End-Organ Damage | Image Credit: Mayo Clinicn HFpEF
© 2024 MJH Life Sciences

All rights reserved.